Stockreport

BioNTech to Acquire Biotheus to Boost Oncology Strategy

BioNTech SE - American Depositary Shares  (BNTX) 
PDF Acquisition to support the global execution of BioNTech’s oncology strategy and provide full global rights to BNT327/PM8002, an investigational PD-L1 x VEGF-A bispecific [Read more]